Get the Stockscreener App
2.16
5.26%
-0.12
After Hours:
2.21
0.05
+2.31%
Black Diamond Therapeutics Inc Stock (BDTX) Latest News
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Short Interest Update - MarketBeat
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Sees Significant Decline in Short Interest - Defense World
NAYA Biosciences Announces Nomination of New Board Members - The Manila Times
February 2025 US Penny Stocks With Promising Prospects - Simply Wall St
SG Americas Securities LLC Makes New $42,000 Investment in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Black Diamond Therapeutics Inc (BDTX) Stock: A Year of Market Fluctuations - The InvestChronicle
PL’s Stock Market Adventure: 60.64% YTD Growth Amidst Volatility - The InvestChronicle
Cemex S.A.B. De C.V. ADR’s: Contrasting Stock Performances in a Volatile Market - The InvestChronicle
Black Diamond Therapeutics Inc (BDTX) Stock: 52-Week Performance Insights and Trading Volume - The InvestChronicle
Axcelis Technologies Inc (ACLS) Shares Down Despite Recent Market Volatility - The News Heater
Analyzing the Price-to-Earnings Ratio of Black Diamond Therapeutics Inc (BDTX) - The News Heater
Molina Healthcare Inc’s Banking’s 100-Day Moving Average at 311.64: Will the Stock Break Through? - The InvestChronicle
Analyzing the Price-to-Earnings Ratio of Smithfield Foods, Inc (SFD) - The News Heater
CPAY Stock Sees Surge of Approximately 1.95% in Last Five Days - Knox Daily
Black Diamond Therapeutics Inc [BDTX] Records 200-Day SMA of $4.25 - Knox Daily
CVRx Inc [CVRX] Shares Fall -7.20 % on Wednesday - Knox Daily
Post Holdings Inc [POST] Shares Jump Approximately 3.76% Over the Year - Knox Daily
How to interpret Black Diamond Therapeutics Inc (BDTX)’s stock chart patterns - US Post News
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Sees Significant Growth in Short Interest - MarketBeat
Trading Day Triumph: Fractyl Health Inc (GUTS) Ends at 1.70, a -7.61 Surge/Plunge - The Dwinnex
Investor’s Delight: Relmada Therapeutics Inc (RLMD) Closes Weak at 0.34, Down -2.61 - The Dwinnex
BRAF Inhibitors Market to Register Incremental Growth During the Study Period (2020–2034) | DelveInsight - GlobeNewswire
BRAF Inhibitors Market to Register Incremental Growth During the Study Period (2020–2034) | DelveInsight - GlobeNewswire Inc.
Barclays PLC Has $339,000 Holdings in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Critical Comparison: Black Diamond Therapeutics (NASDAQ:BDTX) & Cardiol Therapeutics (NASDAQ:CRDL) - Defense World
3 US Penny Stocks With Market Caps Under $200M - Simply Wall St
Why Sage Therapeutics Shares Are Trading Higher By Over 34%; Here Are 20 Stocks Moving Premarket - Benzinga
Pre-market Movers: SAGE, ITCI, GCTK, MRNA... - RTTNews
Raymond James Predicts Up to ~930% Rally for These 2 ‘Strong Buy’ Stocks - Yahoo Finance
Are Medical Stocks Lagging Aptevo Therapeutics (APVO) This Year? - Yahoo Finance
BDTX stock touches 52-week low at $2.08 amid market challenges - Investing.com
Roche purchases shares in tender offer for Poseida Therapeutics, Inc. - Yahoo Finance
Soleno Therapeutics, Inc. (NASDAQ:SLNO): When Will It Breakeven? - Yahoo Finance
XORTX Adds Late Stage Gout Program to Pipeline - Yahoo Finance
Geode Capital Management LLC Raises Holdings in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Geode Capital Management LLC Grows Stock Holdings in BARK, Inc. (NYSE:BARK) - Defense World
Barclays PLC Acquires 11,273 Shares of Acrivon Therapeutics, Inc. (NASDAQ:ACRV) - Defense World
Geode Capital Management LLC Buys 50,579 Shares of Design Therapeutics, Inc. (NASDAQ:DSGN) - Defense World
Barclays PLC Has $339,000 Stock Holdings in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Why Is Summit Therapeutics Inc. (SMMT) Among the Best Multibagger Stocks to Buy Right Now? - Yahoo Finance
State Street Corp Buys 118,764 Shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Black Diamond Therapeutics: Speculative Buy With Precision Oncology Catalysts (BDTX) - Seeking Alpha
Barclays PLC Has $1.10 Million Holdings in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - Defense World
Sarepta Therapeutics, Inc. (SRPT): Is This Gene Therapy Stock a Good Buy Right Now? - Yahoo Finance
Analysts Expect Breakeven For Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Before Long - Yahoo Finance
Will TG Therapeutics, Inc. (TGTX) Make You Rich In 2025? - Yahoo Finance
Is Sarepta Therapeutics, Inc. (SRPT) the Best Performing Biotech Stock in 2024? - Yahoo Finance
Aligos Therapeutics, Inc.'s (NASDAQ:ALGS) biggest owners are retail investors who got richer after stock soared 17% last week - Yahoo Finance
Charles Schwab Investment Management Inc. Boosts Stock Position in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
BDTX stock touches 52-week low at $2.31 amid market challenges - Investing.com India
Analytical Overview: Black Diamond Therapeutics Inc (BDTX)’s Ratios Tell a Financial Story - The Dwinnex
Fmr LLC Makes New Investment in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Akava Therapeutics, Inc. congratulates SAB Chair Dr. Hande Ozdinler, Founder Dr. Richard B. Silverman, and Dr. William Klein on their recent grant of $7.3 million from the National Institute on Aging to investigate AKV9 in neurodegenerative diseases - Yahoo Finance
Checkpoint stock on watch after FDA nod (CKPT:NASDAQ) - Seeking Alpha
0.27%
3.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):